Characterize Metzker Pigmentary Disorders

Mosaicism Clinical Trial

Official title:

Characterize Metzker Pigmentary Disorders

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04966533
• Other study ID #: RECHMPL21_0383
• Status: Completed
• Start date: January 1, 2005
• Est. completion date: June 30, 2021

Study information

• Verified date: July 2021
• Source: University Hospital, Montpellier
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Metzker pigmentary disorders are frequent cause of consultation in pediatric dermatology. The investigators can describe 4 patterns. They must be differentiated from mosaicisms because they aren't associated with neurologic disorders and don't require any follow up.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 74
• Est. completion date: June 30, 2021
• Est. primary completion date: January 30, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 18 Years

Eligibility

Inclusion criteria:

• Metzker pigmentary disorder, age between birth and 18 years old

Exclusion criteria:

• None

Related Conditions & MeSH terms

• Mosaicism

Locations

Country	Name	City	State
France	Uh Montpellier	Montpellier

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Metzker pigmentary disorder pattern	Plume of smoke/ Cloud/Flag/ Linear	1 day
Secondary	Rate of Evolution	Stability/ partial regression/aggravation	1 day